Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT04328207
- Status
- Completed
Conditions
- Behavior, Health
- Cataract
- Diabetic Retinopathy
- Glaucoma
- Refractive Errors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- No Financial Incentive — OTHERStandard of care eye health education
- Financial Incentive — BEHAVIORALPatients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
Study Details
Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.
Key Dates
- Start date
- Nov 18, 2020
- Status verified
- Jul 2025
- Primary completion
- Jul 1, 2024
- Completion
- Jul 1, 2024
Study Design
- Enrollment
- 900 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Other: No financial incentiveThis group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
- Experimental: Financial incentiveThis group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Primary Outcome Measure
Percentage of Participants That Adhere to Referral Appointment [ Time Frame: The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | - |
Find similar trials in Birmingham, AL
Related Studies
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic RetinopathyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- IC-8 Apthera IOL New Enrollment Post Approval StudyRecruiting · Bausch & Lomb Incorporated · Dothan, Alabama
- The Fit With Us StudyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama